The Yale Transdisciplinary Collaborative Center for Health Disparities Research focused on Precision Medicine (Yale-TCC) is a collaboration between the Equity Research and Innovation Center (ERIC) and health, policy, and community leaders in Region II (New York, New Jersey, Puerto Rico, US Virgin Islands), Trinidad, and Barbados. The Yale-TCC builds upon the infrastructure and knowledge of the Eastern Caribbean Health Outcomes Research Network (ECHORN) to generate novel science, strengthen partnerships, and implement interventions to reduce the burden of non-communicable diseases within Region II and the Caribbean.
The Yale-TCC, funded by the National Institute of Health/National Institute of Minority Health and Disparities (NIH/NIMHD), aims to: 1. Utilize a precision medicine approach to inform a broad range of robust research and programmatic activities to advance scientific knowledge, technical capacity, and clinical practice that address the early detection and primary prevention of hypertension and type 2 diabetes in Region II, Trinidad, and Barbados. 2. Develop, launch, and evaluate a series of activities and events to promote a collaborative and multidirectional learning environment across the Yale-TCC. 3. Disseminate and communicate findings internal and external to the YALE-TCC to promote diffusion, uptake, and scale up of evidence-based and cost-effective interventions.